Curaleaf International
Generated by Meeveem AI
"Leading pharmaceutical-grade medical cannabis across Europe, Canada and Australasia"
London
•51 - 250 Employees
•Pharmaceuticals
About Curaleaf International
Curaleaf International produces and distributes pharmaceutical-grade medical cannabis across Europe, Canada and Australasia. The company operates an integrated supply chain from cultivation to distribution, with EU GMP-certified facilities covering over 30,000 square metres. Partnerships with Imperial College London and the University of Pennsylvania advance clinical research whilst products reach clinics and pharmacies in more than 15 countries. Patients benefit from consistent, third-party tested products delivered through specialist clinics and an online pharmacy. Healthcare professionals access real-world evidence via the UK Medical Cannabis Registry, Europe's largest, shaping a future where cannabis-based treatments reach those who need them.
170
Team Members
2018
Founded
Pharmaceuticals
Sector
Hybrid
Work Environment
Our Vision
A world where evidence-based cannabis therapies are readily available to every patient who may benefit, supported by rigorous research, trusted quality standards and global healthcare acceptance.
Our Mission
To shape the future of cannabis through our commitment to research and product excellence.